[1]
|
Hennenfent, K.L. and Govindan, R. (2006) Novel formulations of taxanes: A review. Old wine in a new bottle? Annals of Oncology, 17(5), 735-749.
|
[2]
|
Kruh, G.D. (2005) Ins and outs of taxanes. Cancer Biology &Therapy, 4(9), 1030-1032.
|
[3]
|
Seydel, J.K. and Wiese, M. (2002) Drug-membrane interactions, analysis, drug distribution, modeling. In: Mannhold, R., Kubinyi, H. and Folkers, G., Eds., Methods and Principles in Medicinal Chemistry, Wiley-VCH Verlag GmbH, Weinheim, 15.
|
[4]
|
Günzler, H. and Gremlich, H.-U. (2002) IR spectroscopy. An introduction. Wiley-VCH Verlag GmbH, Weinheim, 69469.
|
[5]
|
Liggins, R.T., Hunter, W.L. and Burt, H.M. (1997) Solid- state characterization of paclitaxel. Journal of Pharmaceutical Sciences, 86(12), 1458-1463.
|
[6]
|
Lee, J.H., Gi, U.-S., Kim, J.-H., Kim, Y., Kim, S.-H., Oh, H. and Min, B. (2001) Preparation and characterization of solvent induced dihydrated, anhydrous, and amor- phous Paclitaxel. Bulletin of the Korean Chemical Society, 22(4), 925-928.
|
[7]
|
Farsad K. and De Camilli, P. (2003) Mechanisms of membrane deformation. Current Opinion in Cell Biology, 15(4), 372-381.
|